Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-10-03
2006-10-03
Minnifield, N. M. (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023500, C536S023400, C536S023700, C435S069100, C435S069300, C435S069700, C435S071100, C435S071200, C435S091100, C435S320100, C435S252300, C435S252320, C435S252330, C435S252310, C435S252500, C435S254400, C435S252800, C435S440000
Reexamination Certificate
active
07115725
ABSTRACT:
Disclosed is DNA encoding diphtheria toxin polypeptides having multiple mutations, which render the polypeptides useful as vaccines.
REFERENCES:
patent: 4709017 (1987-11-01), Collier et al.
patent: 4830962 (1989-05-01), Gelfand et al.
patent: 4950740 (1990-08-01), Greenfield et al.
patent: 5149532 (1992-09-01), Brunell
patent: 5366874 (1994-11-01), Eidels et al.
patent: 5601827 (1997-02-01), Collier et al.
patent: 5917017 (1999-06-01), Collier et al.
patent: 6455673 (2002-09-01), Collier
patent: 2002/0039588 (2002-04-01), Collier et al.
patent: 2003/0050447 (2003-03-01), Collier
patent: 2005/0196407 (2005-09-01), Young et al.
patent: WO92/00099 (1992-01-01), None
patent: WO 93/21769 (1993-11-01), None
patent: WO93/25210 (1993-12-01), None
patent: WO95/33481 (1995-12-01), None
Fu et al, Adv. Exp. Med. Biol., 1997, 419:45-52 Abstract Only.
Mitamura et al, J. Biol. Chem., Oct. 1997, 272/43:27084-90 Abstract Only.
Shen et al., “Participation of Lysine 516 and phenylalanine 530 of diphtheria toxin in receptor recognition”, Journal of Biological Chemistry, 1994 vol. 269, No. 46, pp. 29077-29083, XP002153861 (abstract).
Tortorella et al., “Immunochemical analysis shows all three domains of diphtheria toxin penetrate across model membranes”, J. Biol. Chem. 1995, vol. 270, No. 46, pp. 27446-27452, XP002153877 (abstract).
PCT Search Report, Mailing date Dec. 18, 2000, International Filing Date PCT/US 00/03735.
Kaul, Poonam et al., “Roles of Glu 349 and Asp 352 in membrane insertion and translocation by diphtheria toxin” Database accession No. 124:253099, XP002153862 (abstract).
Rolf et al, Infection and Immunity 1993, 61; 994-1003, Mar. 1993.
Cieplak et al.; Proc. Nat. Acad. Sci., USA 85:4667-4671; 1988.
Barbieri, et al.; “Expression of a Mutant, Full-Length Form of Diphtheria Toxin inEscherichia coli”; Infection and Immunity 55:1647-1651; 1987.
Fisher et al.; “Construction and Expression of Plasmids Containing Mutated Diphtheria Toxin A-Chain-Coding Sequences”; Infection and Immunity 59:3562-3565; 1991.
Giannini, et al.; “The Amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197”; Nucleic Acids Research 12:4063-4069; 1984.
Greenfield et al.; “Mutations in Diphtheria Toxin Separate Binding from Entry and Amplify Immunotoxin Selectivity”; Science 238:536-539; 1987.
Greenfield et al.; “Nucleotide sequence of the structural gene for diphtheria toxin carried by corynebacteriophage β”; PNAS 80:6853-6857; 1983.
Locht et al.; “Identification of amino acid residues essential for the enzymatic activities of pertussis toxin”; PNAS 86:3075-3079; 1989.
Tweten et al.; “Diphtheria Toxin, Effect of Substituting Aspartic Acid for Glutamic Acid 148 on Adp-Ribosyltyr-ansferase Activity”; The J. of Biol. Chem. 260:10392-10394; 1985.
Maxwell et al.; “Cloning, Sequence Determination, and Expression in Transfected Cells of the Coding Sequence of the tox 176 Attenuated Diphtheria Toxin A Chain”; Mol. And Cell. Bio. 7:1576-1579; 1987.
Tang et al.; “Genetic immunization is a simple method for eliciting an immune response”; Nature 356: 152-154; 1973.
Uchida et al.; “Mutation in the Structural Gene for Diphtheria Toxin carried by Temperate Phage β”; Nature New Biology 33:8-11; 1971.
Uchida et al.; “Diphtheria Toxin and Related Proteins”; The J. of Bio. Chem.. 248:3838-3844; 1973.
Ward; “Diphtheria toxin: a novel cytocidal enzyme”; Trends Biochem. 12:28-30; 1987.
Wilson et al.; “Active-Site of Diphtheria Toxin: Effects of Replacing Glutamic Acid-148 with Aspartic Acid, Glutamine, or Serine”; Biochem 29:8643-8651; 1990.
Choe et al.; “The crystal structure of diphtheria toxin”; Nature 357:216-222; 1992.
Lukac et et al.; “Toxoid ofPseudomonas AeruginosaExotoxin A Generated by Deletion of an Active-Site Residue”; Infect. Immun. 56:3095-3098; 1988.
Killeen et al.; “Reversion of recombinant toxoids: Mutations in diphtheria toxin that partially compensate for active-site deletions”; Proc. Natl. Acad. Sci. USA 89:6207-6209; Jul. 1992.
Killeen et al.; “Conformational integrity of a recombinant toxoid ofPseudomonas aeruginosaexotoxin A containing a deletion of glutamic acid-553”; Biochimica et Biophysica Acta 1138:162-166; 1992.
Williams et al., “Cellular Processing of the Interleukin . . . Cells Requires Arg194,” J. Biol. Chem. 265 (1990) 20673-7.
Fish & Richardson P.C.
Minnifield N. M.
President and Fellows of Harvard College
LandOfFree
Multi-mutant diphtheria toxin vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multi-mutant diphtheria toxin vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-mutant diphtheria toxin vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3701149